Forbes December 1, 2024
Medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become very popular as weight loss agents. Taken in accordance with the instructions on the label and an appropriate diet and exercise regimen, GLP-1s are effective at lowering a person’s weight.
But what about obesity prevention? What is sometimes missing in current discussions on obesity in the media and elsewhere is the role of prevention. Ideally, a newly revamped Department of Health and Human Services could reshape the nation’s food and nutrition ecosystem in addition to prioritizing more physical activity. But caution is warranted, as previous administrations as well as the current Becerra-led HHS, have attempted to address these issues. And thus far they haven’t accomplished the desired results.
About 40%...
Today's Sponsors
Today's Sponsor